Echo as a prognostic tool in COVID-19

The recent publication in Medscape, an online medical knowledge resource platform for medical professionals, suggests that echocardiography (2D transthoracic echocardiography) is the best practical prognostic measure for in-hospital patient mortality assessment.

The studies in New York City and Milan hospitals concluded that troponin studies should be carried with further echo studies for COVID-19 positive patients.

It demonstrates that increased troponin level along with echocardiography findings suggest a greater risk of mortality from the disease. The most common echocardiographic findings in patients positive for COVID-19 and related to poorer outcomes are “right-sided ventricular dysfunction in 26.3%, left-sided ventricular dysfunction in 23.7% of patients; left-ventricular global dysfunction in 18.4%; grade II or III diastolic dysfunction in 13.2%, and pericardial effusion in 7.2% of patients

2D echocardiography is a relatively cheap and accessible method of choice to extensively evaluate heart function in COVID-19 positive patients.

Share the Post:

Related Posts

In a bold stride towards innovation, we are excited to announce the latest enhancements to our flagship product, the Ligence Heart web app software. Through meticulous development and optimization, we've
The course covers several topics related to AI in echocardiography, including successful examples, clinical benefits, and the current state of AI in stress echocardiography. The event also features a presentation